Form 4: EKSO CFO Boosts Stake via 401(k) Plan

Jerome Wong, Chief Financial Officer of EKSO Bionics Holdings, Inc., acquired 1,308 shares of common stock at $11.85 per share through the company's 401(k) matching program.

Summary

• Jerome Wong, Chief Financial Officer of EKSO Bionics Holdings, Inc. (EKSO), acquired 1,308 shares of common stock.
• The acquisition occurred on March 16, 2026, at a price of $11.85 per share.
• These shares were obtained in connection with the Issuer's 401(k) contribution matching program.
• Following this transaction, Mr. Wong indirectly beneficially owns 4,184 shares via his 401(k) and directly owns 24,771 shares.
• All reported share amounts have been adjusted to reflect a 1-for-15 reverse stock split effected on June 2, 2025.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as insider buying, even through a 401(k) plan, generally indicates management confidence in the company's value.

Positives

• Insider acquisition of shares, even through a 401(k) plan, can signal management's confidence in the company's future prospects.
• The transaction occurred at a specific valuation point of $11.85 per share, indicating the price at which the insider chose to increase their stake.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider purchases, even through routine mechanisms like 401(k) plans, can be interpreted by the market as a positive signal regarding management's belief in the company's valuation and future prospects. The mention of a prior reverse stock split on June 2, 2025, suggests the company may have faced challenges in maintaining its share price, a common occurrence in the medical device or robotics industry for smaller players, but this transaction itself is a standard insider disclosure.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management's belief in the company's long-term value.

Key Dates

Keywords

EKSO Bionics, EKSO, Jerome Wong, CFO, Insider Trading, Form 4, Stock Acquisition, 401(k), Beneficial Ownership, Reverse Stock Split